High-dose therapy and autologous hematopoietic cell transplantation as consolidation treatment for primary effusion lymphoma
ConclusionDespite the small sample size, our data show that consolidative auto-HCT is safe and could be considered for eligible PEL patients after induction chemotherapy. However, a high relapse rate is concerning and warrants incorporation of new strategies to mitigate post-transplantation relapse.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Academia | Cancer & Oncology | Chemotherapy | Herpes | Hodgkin's Disease | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | Study | Transplants